Search Results 1661-1670 of 16805 for monoclonal antibody
... antibody or treatment specifically targeting T-cell co-stimulation or immune checkpoint pathways). Participants with toxicities that are unlikely to recur ...
They are also investigating drugs — such as mimetic agents, targeted antibodies and small molecules — that could specifically block this site responsible for ...
Leif Bergsagel, M.D.. Internist; Oncologist. Phoenix, AZ. Areas of focus: Amyloidosis, Multiple myeloma, Waldenstrom macroglobulinemia, Monoclonal gammopathy of ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
Biotinylated antibodies against CD40, CD86, CD11b, CD11c and MHC II. Biotinylated protein ligands targeting toll-like receptors and scavenger receptors ...
Current hepatitis C infection (defined as positive HCV antibody and detectable HCV RNA. Participants with positive HCV antibody and undetectable HCV RNA are ...
These individuals will require HCV ribose nucleic acid (RNA) quantitative PCR for confirmation of active disease -Individuals who test positive for HIV antibody ...
It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, such as ...
Any immunotherapy or other antibody therapy within 28 days prior to the first dose of study drug (immune related toxicities must have resolved to < Grade 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.